Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

177 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Neoadjuvant cobimetinib and atezolizumab with or without vemurafenib for high-risk operable Stage III melanoma: the Phase II NeoACTIVATE trial.
Hieken TJ, Nelson GD, Flotte TJ, Grewal EP, Chen J, McWilliams RR, Kottschade LA, Yang L, Domingo-Musibay E, Dronca RS, Yan Y, Markovic SN, Dimou A, Montane HN, Erskine CL, Piltin MA, Price DL, Khariwala SS, Hui J, Strand CA, Harrington SM, Suman VJ, Dong H, Block MS. Hieken TJ, et al. Among authors: flotte tj. Nat Commun. 2024 Feb 16;15(1):1430. doi: 10.1038/s41467-024-45798-8. Nat Commun. 2024. PMID: 38365756 Free PMC article. Clinical Trial.
Resolving the heterogeneous tumor-centric cellular neighborhood through multiplexed, spatial paracrine interactions in the setting of immune checkpoint blockade.
Maus RLG, Leontovich AL, Moore RM, Becher L, Nevala WK, Flotte TJ, Guo R, Schimke J, Dicke BA, Yan Y, Markovic SN. Maus RLG, et al. Among authors: flotte tj. Cancer Res Commun. 2022 Feb;2(2):78-89. doi: 10.1158/2767-9764.crc-21-0146. Epub 2022 Feb 10. Cancer Res Commun. 2022. PMID: 35992329 Free PMC article.
Metastatic malignant melanoma.
Markovic SN, Erickson LA, Flotte TJ, Kottschade LA, McWilliams RR, Jakub JW, Farley DR, Tran NV, Schild SE, Olivier KR, Vuk-Pavlovic S, Sekulic A, Weenig RH, Pulido JS, Quevedo JF, Vile RG, Wiseman GA, Stoian I, Pittelkow MR; Melanoma Study Group of the Mayo Clinic Cancer Center. Markovic SN, et al. Among authors: flotte tj. G Ital Dermatol Venereol. 2009 Feb;144(1):1-26. G Ital Dermatol Venereol. 2009. PMID: 19218908 Review.
Targeting the cyclin dependent kinase and retinoblastoma axis overcomes standard of care resistance in BRAF V600E -mutant melanoma.
Harris AL, Lee SE, Dawson LK, Marlow LA, Edenfield BH, Durham WF, Flotte TJ, Thompson M, Small DL, Synnott AJ, Markovic SN, Copland JA. Harris AL, et al. Among authors: flotte tj. Oncotarget. 2017 Dec 23;9(13):10905-10919. doi: 10.18632/oncotarget.23649. eCollection 2018 Feb 16. Oncotarget. 2017. PMID: 29541385 Free PMC article.
Understanding heterogeneous tumor microenvironment in metastatic melanoma.
Yan Y, Leontovich AA, Gerdes MJ, Desai K, Dong J, Sood A, Santamaria-Pang A, Mansfield AS, Chadwick C, Zhang R, Nevala WK, Flotte TJ, Ginty F, Markovic SN. Yan Y, et al. Among authors: flotte tj. PLoS One. 2019 Jun 5;14(6):e0216485. doi: 10.1371/journal.pone.0216485. eCollection 2019. PLoS One. 2019. PMID: 31166985 Free PMC article.
177 results